Cart
sales@molnova.com
Ingliforib
CAS No. 186392-65-4
Ingliforib ( CP 368296; GPi 296 )
Catalog No. M21834 CAS No. 186392-65-4
Ingliforib is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 209 | In Stock |
|
| 10MG | 336 | In Stock |
|
| 25MG | 572 | In Stock |
|
| 50MG | 807 | In Stock |
|
| 100MG | 1107 | In Stock |
|
| 200MG | 1494 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIngliforib
-
NoteResearch use only, not for human use.
-
Brief DescriptionIngliforib is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.
-
DescriptionIngliforib is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.
-
SynonymsCP 368296; GPi 296
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number186392-65-4
-
Formula Weight457.91
-
Molecular FormulaC23H24ClN3O5
-
Purity>98% (HPLC)
-
SolubilityDMSO : 130 mg/mL (283.90 mM; Need ultrasonic)
-
SMILESO=C(C(N1)=CC2=C1C=CC(Cl)=C2)N[C@@H](CC3=CC=CC=C3)[C@@H](O)C(N4C[C@@H](O)[C@@H](O)C4)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tracey WR, et al. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor. Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1177-84.
molnova catalog
related products
-
Trigonelline
Trigonelline, an alkaloid with potential antidiabetic activity, is present in considerable amounts in coffee.
-
Margaritene
Margaritene is a natural product for research related to life sciences.
-
Orexin A (human, rat...
Endogenous agonist at orexin receptors (Ki values are 20 and 38 nM for OX1 and OX2 receptors respectively). Stimulates feeding following central administration and may be involved in the control of sleep-wake cycle and other hypothalamic functions.
